NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDUblituximab Briumvi®
(150 mg concentrate for solution for infusion) 		Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Ublituximab Ublituximab Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1025: Ublituximab for treating relapsing multiple sclerosis